Danaher (DHR) to Announce Earnings on Tuesday

Danaher (NYSE:DHR) is projected to post its Q2 2026 results before the market opens on Tuesday, July 21st. Analysts expect Danaher to announce earnings of $1.84 per share and revenue of $6.1059 billion for the quarter. Investors may visit the the company’s upcoming Q2 2026 earning summary page for the latest details on the call scheduled for Tuesday, July 21, 2026 at 8:00 AM ET.

Danaher (NYSE:DHR) last posted its earnings results on Monday, April 20th. The conglomerate reported $2.06 earnings per share for the quarter, beating analysts’ consensus estimates of $1.94 by $0.12. Danaher had a net margin of 14.89% and a return on equity of 10.91%. The firm had revenue of $5.95 billion during the quarter, compared to analyst estimates of $6 billion. During the same period last year, the firm posted $1.88 earnings per share. Danaher’s revenue for the quarter was up 3.7% compared to the same quarter last year. On average, analysts expect Danaher to post $8 EPS for the current fiscal year and $9 EPS for the next fiscal year.

Danaher Trading Down 0.7%

Shares of DHR opened at $203.65 on Friday. The stock has a market capitalization of $144.14 billion, a PE ratio of 39.39, a P/E/G ratio of 2.51 and a beta of 0.79. The company’s fifty day moving average is $183.27 and its 200 day moving average is $198.47. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.52 and a current ratio of 1.87. Danaher has a fifty-two week low of $160.93 and a fifty-two week high of $242.80.

Danaher Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Friday, June 26th will be paid a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.8%. The ex-dividend date of this dividend is Friday, June 26th. Danaher’s dividend payout ratio (DPR) is presently 30.95%.

Analysts Set New Price Targets

Several analysts have recently issued reports on DHR shares. JPMorgan Chase & Co. decreased their target price on shares of Danaher from $275.00 to $245.00 and set an “overweight” rating on the stock in a research report on Wednesday, April 22nd. UBS Group dropped their price target on Danaher from $270.00 to $250.00 and set a “buy” rating for the company in a research report on Wednesday, April 22nd. Guggenheim reduced their price objective on Danaher from $275.00 to $235.00 and set a “buy” rating on the stock in a research note on Wednesday, April 22nd. Wells Fargo & Company decreased their price objective on Danaher from $240.00 to $212.00 and set an “equal weight” rating on the stock in a research report on Wednesday, April 22nd. Finally, Rothschild & Co Redburn set a $205.00 price objective on Danaher in a research note on Friday, April 17th. One research analyst has rated the stock with a Strong Buy rating, eighteen have assigned a Buy rating and five have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $231.64.

Hedge Funds Weigh In On Danaher

Hedge funds have recently bought and sold shares of the business. Compound Planning Inc. increased its stake in Danaher by 47.1% in the 4th quarter. Compound Planning Inc. now owns 9,554 shares of the conglomerate’s stock worth $2,187,000 after buying an additional 3,060 shares during the period. Invesco Ltd. lifted its holdings in Danaher by 8.1% during the 4th quarter. Invesco Ltd. now owns 4,120,223 shares of the conglomerate’s stock valued at $943,201,000 after buying an additional 307,095 shares in the last quarter. Birchwood Financial Partners Inc. purchased a new stake in Danaher in the 4th quarter valued at about $41,000. Corient Private Wealth LLC boosted its position in Danaher by 2.0% in the 4th quarter. Corient Private Wealth LLC now owns 1,025,570 shares of the conglomerate’s stock valued at $228,812,000 after buying an additional 19,852 shares during the period. Finally, Alpine Woods Capital Investors LLC bought a new position in Danaher in the 4th quarter worth about $231,000. Institutional investors own 79.05% of the company’s stock.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.